UVM Medical Center hopeful for promising results from RSV vaccine research
WCAX
RSV spiked in Vermont last fall, but the medical community is hopeful that won’t happen this year thanks to an immunization a decade in the making.
In the 2022-2023 school year, 94% of K-12 students were immunized for sicknesses ranging from polio to hepatitis B.
But last year, students might remember the flu, COVID and RSV going around, too. A researcher at UVM helped make strides for an RSV vaccine.
RSV can feel like a cold for most people, but babies and toddlers can have a hard time fighting it.
“About half of the hospitalizations at one point were due to RSV. So that created an extremely high workload for everybody,” said Sean Diehl, an associate professor of microbiology and microgenetics at the UVM Larner College of Medicine.